2024 - NAMS Menopause Certification Exam Study Set
EXAM / NAMS Menopause Certification REAL EXAM
TESTBANK ALL ACTUAL QUESTIONS AND WELL
ELABORATED ANSWERS (VERIFIED ANSWERS) A NEW
UPDATED VERSION 2026-2027 | GUARANTEED PASS
A+ (BRAND NEW!!)
Produced by granulosa cells of activated follicles, most reflective of true
ovarian reserve; provides the best single prediction of time to menopause
AMH
what day of cycle to draw FSH to predict ovarian response/reserve?
day 3
normal day 3 FSH?
FSH value for menopause?
< 10
>25
# of ultrasound detected follicles 2-10 mm in size
AFC (antral follicle count)
,normal AFC
>12
Luteal-Out-Of-Phase (LOOP) event
- FSH elevation recruits follicles for the subsequent cycle before the current
cycle is over
- Excess estradiol production as new follicles start growing
- Increase chance of TWINS
- Very short follicular phase
- More time spent in luteal phase (more PMS/PMDD sx)
symptoms of LOOP event
—Mastalgia
—Worsening migraine
—Growing fibroids
—Risk of endometrial hyperplasia
- longer time in luteal phase (worsening PMDD in peri)
,premenopausal vs postmenopausal estradiol levels in obesity
pre: lower, more anovulatory cycles
post: higher
consequence of inhibin B and AMH drop in early menopause transition?
FSH spikes --> fast growth of remaining follicles (twins more likely) --> shorter
follicular phase --> follicle atresia --> LOOP cycles --> pronounced PMS sx
from longer luteal phase --> cycle irregularity by >7 days
dec ovarian reserve causes the drop in what 2 hormones?
inhibin B and AMH
4 adrenal androgens
—Dehydroepiandrosterone (DHEA)
—Dehydroepiandrosterone sulfate (DHEAS)
—Androstenedione
—Testosterone
where are adrenal androgens converted to estrogen?
peripheral tissue
, what happens to DHEA levels during menopause transition?
transient increase then return to premenopause baseline
is DHEA supplementation in menopause recommended?
no
(Systematic review and meta-analysis of DHEA use in postmenopausal women
with normal adrenal function found no evidence of improvement in sexual
symptoms, serum lipids, serum glucose, weight, or bone mineral density)
dx of POI?
amenorrhea >4 mo in age <40
FSH >25 on 2 occasions
4 etiologies of POI
most common?
(1) Genetic (turner, fragile X)
(2) Autoimmune (adrenal Ab/Addison's)
(3) Cancer (chemo, radiation, surgical oophrectomy)
(4) Idiopathic --> most common
EXAM / NAMS Menopause Certification REAL EXAM
TESTBANK ALL ACTUAL QUESTIONS AND WELL
ELABORATED ANSWERS (VERIFIED ANSWERS) A NEW
UPDATED VERSION 2026-2027 | GUARANTEED PASS
A+ (BRAND NEW!!)
Produced by granulosa cells of activated follicles, most reflective of true
ovarian reserve; provides the best single prediction of time to menopause
AMH
what day of cycle to draw FSH to predict ovarian response/reserve?
day 3
normal day 3 FSH?
FSH value for menopause?
< 10
>25
# of ultrasound detected follicles 2-10 mm in size
AFC (antral follicle count)
,normal AFC
>12
Luteal-Out-Of-Phase (LOOP) event
- FSH elevation recruits follicles for the subsequent cycle before the current
cycle is over
- Excess estradiol production as new follicles start growing
- Increase chance of TWINS
- Very short follicular phase
- More time spent in luteal phase (more PMS/PMDD sx)
symptoms of LOOP event
—Mastalgia
—Worsening migraine
—Growing fibroids
—Risk of endometrial hyperplasia
- longer time in luteal phase (worsening PMDD in peri)
,premenopausal vs postmenopausal estradiol levels in obesity
pre: lower, more anovulatory cycles
post: higher
consequence of inhibin B and AMH drop in early menopause transition?
FSH spikes --> fast growth of remaining follicles (twins more likely) --> shorter
follicular phase --> follicle atresia --> LOOP cycles --> pronounced PMS sx
from longer luteal phase --> cycle irregularity by >7 days
dec ovarian reserve causes the drop in what 2 hormones?
inhibin B and AMH
4 adrenal androgens
—Dehydroepiandrosterone (DHEA)
—Dehydroepiandrosterone sulfate (DHEAS)
—Androstenedione
—Testosterone
where are adrenal androgens converted to estrogen?
peripheral tissue
, what happens to DHEA levels during menopause transition?
transient increase then return to premenopause baseline
is DHEA supplementation in menopause recommended?
no
(Systematic review and meta-analysis of DHEA use in postmenopausal women
with normal adrenal function found no evidence of improvement in sexual
symptoms, serum lipids, serum glucose, weight, or bone mineral density)
dx of POI?
amenorrhea >4 mo in age <40
FSH >25 on 2 occasions
4 etiologies of POI
most common?
(1) Genetic (turner, fragile X)
(2) Autoimmune (adrenal Ab/Addison's)
(3) Cancer (chemo, radiation, surgical oophrectomy)
(4) Idiopathic --> most common
